+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Blood Collection Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 142 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5911815
The global blood collection market size reached US$ 6.6 Billion in 2022. Looking forward, the market is expected to reach US$ 9.0 Billion by 2028, exhibiting a growth rate (CAGR) of 5.31% during 2022-2028.

Blood collection involves the voluntary removal of blood from the body for laboratory analysis. It is usually collected within a hospital environment to identify metabolic, respiratory, and mixed-acid disorders. Some of the popular methods of blood collection are arterial, venipuncture and fingerstick sampling. Blood collection plays a crucial role in understanding, preventing and treating disease across hospitals and blood bank centers. The blood is extracted through automated equipment or manually and then separated into various components using the apheresis process. The blood samples can also be taken from the arm, ear, hand, and other parts of the body, depending on the requirement.

Blood Collection Market Trends

The global blood collection market is primarily driven by the increasing number of surgical procedures performed in hospitals. Blood collection products are used in the treatment of patients undergoing chemotherapy, dialysis, organ and tissue transplantation, and complex surgeries. The growing cases of chronic and lifestyle diseases on account of sedentary lifestyles have also necessitated greater adherence to regular health checkups. This has escalated the need for blood collection as the primary mode of diagnosing diseases. Besides this, governments of several countries are taking initiatives to increase the number of blood donations and create awareness about its importance amidst the outbreak of coronavirus disease (COVID-19). Such programs are driving the blood collection market globally during the pandemic. Furthermore, technological advancements in the field of blood collection are facilitating the market growth. For instance, market players have introduced a push-button blood collection device, which can be used for testing HbA1c levels in diabetic and prediabetic patients. Other factors, including the rising cases of accidents and the adoption of preventive care and diagnostics among individuals, are further expected to drive the market growth.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global blood collection market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on product, application and end use.

Breakup by Product:

  • Needles and Syringes
  • Blood Collection Tubes
  • Serum-separating
  • EDTA
  • Heparin
  • Plasma-separating
  • Blood Bags

Breakup by Application:

  • Diagnostics
  • Treatment

Breakup by End Use:

  • Hospitals
  • Diagnostics Centers
  • Blood Banks

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, FL MEDICAL s.r.l., Greiner AG, Haemonetics Corporation, McKesson Corporation, Medtronic plc, Nipro Corporation, Qiagen N.V., Quest Diagnostics, Sarstedt AG & Co. KG and Terumo Corporation.

Key Questions Answered in This Report

1. What was the size of the global blood collection market in 2022?
2. What is the expected growth rate of the global blood collection market during 2023-2028?
3. What has been the impact of COVID-19 on the global blood collection market?
4. What are the key factors driving the global blood collection market?
5. What is the breakup of the global blood collection market based on the product?
6. What is the breakup of the global blood collection market based on the application?
7. What is the breakup of the global blood collection market based on the end use?
8. What are the key regions in the global blood collection market?
9. Who are the key players/companies in the global blood collection market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Blood Collection Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Needles and Syringes
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Blood Collection Tubes
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Serum-separating
6.2.2.2 EDTA
6.2.2.3 Heparin
6.2.2.4 Plasma-separating
6.2.3 Market Forecast
6.3 Blood Bags
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Application
7.1 Diagnostics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Treatment
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by End Use
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diagnostics Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Blood Banks
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Becton Dickinson and Company
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 FL MEDICAL s.r.l.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Greiner AG
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Haemonetics Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 McKesson Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Medtronic plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Nipro Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Qiagen N.V.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Quest Diagnostics
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Sarstedt AG & Co. KG
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Terumo Corporation
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis

Companies Mentioned

  • Abbott Laboratories
  • Becton Dickinson and Company
  • FL MEDICAL s.r.l.
  • Greiner AG
  • Haemonetics Corporation
  • McKesson Corporation
  • Medtronic plc
  • Nipro Corporation
  • Qiagen N.V.
  • Quest Diagnostics
  • Sarstedt AG & Co. KG
  • Terumo Corporation

Methodology

Loading
LOADING...

Table Information